Freedman Financial Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-48
Closed -$13K 440
2022
Q1
$13K Hold
48
0.01% 334
2021
Q4
$11K Hold
48
0.01% 337
2021
Q3
$9K Hold
48
0.01% 358
2021
Q2
$10K Hold
48
0.01% 346
2021
Q1
$10K Buy
+48
New +$10K 0.01% 357